Home
IMAB
IMAB News

Latest I-MAB (IMAB) News on October 28, 2025

I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025

GlobeNewswire

6 days ago

I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025

I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences

PR Newswire

11 days ago

I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences

MT Newswires

14 days ago

Asian Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading

I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

GlobeNewswire

14 days ago

I-Mab to Present Short-Talk on Updated Givastomig Monotherapy Data at the 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

I-Mab's (NASDAQ:IMAB) market cap surged US$52m last week, individual investors who have a lot riding on the company were rewarded

Simply Wall St.

17 days ago

I-Mab's (NASDAQ:IMAB) market cap surged US$52m last week, individual investors who have a lot riding on the company were rewarded

I-Mab Sponsored ADR (IMAB) Is Up 24.14% in One Week: What You Should Know

Zacks

18 days ago

I-Mab Sponsored ADR (IMAB) Is Up 24.14% in One Week: What You Should Know

What Makes IMab (IMAB) a New Buy Stock

Zacks

22 days ago

What Makes IMab (IMAB) a New Buy Stock

I-Mab Strengthens Givastomig Intellectual Property Portfolio through Acquisition of Bridge Health

GlobeNewswire

3 months ago

I-Mab Strengthens Givastomig Intellectual Property Portfolio through Acquisition of Bridge Health

I-Mab to Present at the BTIG Virtual Biotechnology Conference

GlobeNewswire

3 months ago

I-Mab to Present at the BTIG Virtual Biotechnology Conference

June 2025's Promising Penny Stocks

Simply Wall St.

4 months ago

June 2025's Promising Penny Stocks

I-Mab Highlights Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025

GlobeNewswire

4 months ago

I-Mab Highlights Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025

I-Mab to Host Webinar to Recap New Givastomig Data, in Combination with Immunochemotherapy, Expected at ESMO GI 2025

GlobeNewswire

4 months ago

I-Mab to Host Webinar to Recap New Givastomig Data, in Combination with Immunochemotherapy, Expected at ESMO GI 2025

MT Newswires

5 months ago

I-Mab Says It Has Regained Compliance With Nasdaq's Minimum Bid Price Rule

I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

5 months ago

I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement

I-Mab Sponsored ADR (IMAB)'s Technical Outlook is Bright After Key Golden Cross

Zacks

5 months ago

I-Mab Sponsored ADR (IMAB)'s Technical Outlook is Bright After Key Golden Cross

I-Mab Sponsored ADR (IMAB) is a Great Momentum Stock: Should You Buy?

Zacks

5 months ago

I-Mab Sponsored ADR (IMAB) is a Great Momentum Stock: Should You Buy?

I-Mab to Participate in the H.C. Wainwright “HCW@Home” Series

GlobeNewswire

5 months ago

I-Mab to Participate in the H.C. Wainwright “HCW@Home” Series

Fuel Tech And 2 Other Promising Penny Stocks For Consideration

Simply Wall St.

5 months ago

Fuel Tech And 2 Other Promising Penny Stocks For Consideration

I-Mab to Present at Jefferies Global Healthcare Conference

GlobeNewswire

5 months ago

I-Mab to Present at Jefferies Global Healthcare Conference

I-Mab Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

5 months ago

I-Mab Reports First Quarter 2025 Financial Results and Provides Business Update

I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025

GlobeNewswire

6 months ago

I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025

After Plunging -20.33% in 4 Weeks, Here's Why the Trend Might Reverse for IMab (IMAB)

Zacks

6 months ago

After Plunging -20.33% in 4 Weeks, Here's Why the Trend Might Reverse for IMab (IMAB)

After Plunging -19.7% in 4 Weeks, Here's Why the Trend Might Reverse for IMab (IMAB)

Zacks

7 months ago

After Plunging -19.7% in 4 Weeks, Here's Why the Trend Might Reverse for IMab (IMAB)

I-Mab Reports Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire

7 months ago

I-Mab Reports Full Year 2024 Financial Results and Provides Business Update

I-Mab to Present at 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

7 months ago

I-Mab to Present at 24th Annual Needham Virtual Healthcare Conference

MT Newswires

7 months ago

I-Mab Gets Nasdaq Noncompliance Notice on Bid Price Requirement

I-Mab Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

GlobeNewswire

7 months ago

I-Mab Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

I-Mab Announces Accelerated Givastomig Phase 1b Study Progress

GlobeNewswire

8 months ago

I-Mab Announces Accelerated Givastomig Phase 1b Study Progress

I-Mab to Participate in Leerink Partners Global Healthcare Conference

GlobeNewswire

8 months ago

I-Mab to Participate in Leerink Partners Global Healthcare Conference

I-Mab to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

GlobeNewswire

9 months ago

I-Mab to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member

PR Newswire

10 months ago

I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member

US Penny Stocks To Watch In January 2025

Simply Wall St.

10 months ago

US Penny Stocks To Watch In January 2025

I-Mab pauses CD73 antibody development in pipeline reshuffle

Clinical Trials Arena

10 months ago

I-Mab pauses CD73 antibody development in pipeline reshuffle

MT Newswires

10 months ago

I-Mab to Prioritize Givastomig as Lead Program; Shares Rise

I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program

PR Newswire

10 months ago

I-Mab Announces Portfolio Prioritization of Givastomig (CLDN18.2 x 4-1BB Bispecific Antibody) as Lead Clinical Program

I-Mab Leads Our Spotlight On 3 US Penny Stocks

Simply Wall St.

a year ago

I-Mab Leads Our Spotlight On 3 US Penny Stocks

I-Mab to Participate at the Piper Sandler Healthcare Conference

PR Newswire

a year ago

I-Mab to Participate at the Piper Sandler Healthcare Conference

I-Mab Third Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.57 loss in 3Q 2023)

Simply Wall St.

a year ago

I-Mab Third Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.57 loss in 3Q 2023)

I-Mab Reports Third Quarter 2024 Results

PR Newswire

a year ago

I-Mab Reports Third Quarter 2024 Results

MT Newswires

a year ago

I-Mab Makes Interim CEO Sean Fu Permanent

I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer

PR Newswire

a year ago

I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer

I-Mab to Release Q3 2024 Financial Results on November 14, 2024

PR Newswire

a year ago

I-Mab to Release Q3 2024 Financial Results on November 14, 2024

I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024

PR Newswire

a year ago

I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024

I-Mab to Participate at the Truist Securities BioPharma Symposium

PR Newswire

a year ago

I-Mab to Participate at the Truist Securities BioPharma Symposium

I-Mab Biopharma’s Strategic US Transition and Pipeline Focus

TipRanks

a year ago

I-Mab Biopharma’s Strategic US Transition and Pipeline Focus

IMab (IMAB) Moves to Buy: Rationale Behind the Upgrade

Zacks

a year ago

IMab (IMAB) Moves to Buy: Rationale Behind the Upgrade

MT Newswires

a year ago

I-Mab Cancer Drug Trial Shows 'Encouraging' Topline Data

I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024

PR Newswire

a year ago

I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024

I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer

PR Newswire

a year ago

I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer

I-Mab First Half 2024 Earnings: US$0.19 loss per share (vs US$1.32 loss in 1H 2023)

Simply Wall St.

a year ago

I-Mab First Half 2024 Earnings: US$0.19 loss per share (vs US$1.32 loss in 1H 2023)

I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates

PR Newswire

a year ago

I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates

I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire

a year ago

I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

I-Mab to Release 1H 2024 Financial Results on August 28, 2024

PR Newswire

a year ago

I-Mab to Release 1H 2024 Financial Results on August 28, 2024

I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC)

PR Newswire

a year ago

I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC)

MT Newswires

a year ago

I-Mab Names Wei Fu Chairman, Sean Xi-Yong Fu as Interim CEO

I-Mab Announces Leadership Transitions

PR Newswire

a year ago

I-Mab Announces Leadership Transitions

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

Simply Wall St.

a year ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

a year ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Simply Wall St.

a year ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

a year ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

Motley Fool

a year ago

3 Mistakes That Can Get Your Costco Membership Canceled

While private equity firms own 21% of I-Mab (NASDAQ:IMAB), retail investors are its largest shareholders with 59% ownership

Simply Wall St.

a year ago

While private equity firms own 21% of I-Mab (NASDAQ:IMAB), retail investors are its largest shareholders with 59% ownership

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

PR Newswire

a year ago

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

I-Mab and BMS assess givastomig for gastric and oesophageal cancer

Pharmaceutical Technology

a year ago

I-Mab and BMS assess givastomig for gastric and oesophageal cancer

MT Newswires

a year ago

I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers

PR Newswire

a year ago

I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers

I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024

GlobeNewswire

a year ago

I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024

I-Mab to Participate at the Jefferies Global Healthcare Conference

PR Newswire

a year ago

I-Mab to Participate at the Jefferies Global Healthcare Conference

Thomson Reuters StreetEvents

a year ago

Q1 2024 Summit Therapeutics Inc Earnings Call

I-MAB Filed 2023 Annual Report on Form 20-F

PR Newswire

a year ago

I-MAB Filed 2023 Annual Report on Form 20-F

I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference

PR Newswire

2 years ago

I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference

I-Mab Announces Closing of the Divestiture of Business Operations in China

PR Newswire

2 years ago

I-Mab Announces Closing of the Divestiture of Business Operations in China

I-Mab Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

2 years ago

I-Mab Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

I-Mab Reports Full Year 2023 Financial Results and Business Update

PR Newswire

2 years ago

I-Mab Reports Full Year 2023 Financial Results and Business Update

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Summit Therapeutics Inc Earnings Call

Reuters

2 years ago

UPDATE 2-Biotech firm I-Mab to divest China operations, shift focus to US

I-Mab Signs Agreement to Divest its Assets and Business Operations in China

PR Newswire

2 years ago

I-Mab Signs Agreement to Divest its Assets and Business Operations in China

When Can We Expect A Profit From Youdao, Inc. (NYSE:DAO)?

Simply Wall St.

2 years ago

When Can We Expect A Profit From Youdao, Inc. (NYSE:DAO)?

OP Bancorp Full Year 2023 Earnings: EPS Misses Expectations

Simply Wall St.

2 years ago

OP Bancorp Full Year 2023 Earnings: EPS Misses Expectations

Vera Bradley, Inc. Announces Media Business Executive Jessica Rodriguez to Join Board of Directors

GlobeNewswire

2 years ago

Vera Bradley, Inc. Announces Media Business Executive Jessica Rodriguez to Join Board of Directors

Middlefield Banc Corp. (MBCN) Reports Record Annual Net Income for 2023

GuruFocus.com

2 years ago

Middlefield Banc Corp. (MBCN) Reports Record Annual Net Income for 2023

Energy Vault Expands Global Footprint for Gravity Energy Storage with 10 Year License and Royalty Agreement Covering Southern Africa

Business Wire

2 years ago

Energy Vault Expands Global Footprint for Gravity Energy Storage with 10 Year License and Royalty Agreement Covering Southern Africa

Why QuickLogic (QUIK) Outpaced the Stock Market Today

Zacks

2 years ago

Why QuickLogic (QUIK) Outpaced the Stock Market Today

NOVONIX to Host Fourth Quarter 2023 Operations Update

GlobeNewswire

2 years ago

NOVONIX to Host Fourth Quarter 2023 Operations Update

Endeavour Silver Provides 2024 Update for the Terronera Project; Initial Production Remains on Schedule for End of 2024

GlobeNewswire

2 years ago

Endeavour Silver Provides 2024 Update for the Terronera Project; Initial Production Remains on Schedule for End of 2024

Duluth Holdings Inc. Announces Appointment of Heena Agrawal as Chief Financial Officer

GlobeNewswire

2 years ago

Duluth Holdings Inc. Announces Appointment of Heena Agrawal as Chief Financial Officer

GlobeNewswire

2 years ago

WEYCO Group, Inc. Fourth Quarter and Full Year 2023 Earnings Conference Call

3 Stocks to Sell: Identifying the Weakest Links in the 2024 Market

InvestorPlace

2 years ago

3 Stocks to Sell: Identifying the Weakest Links in the 2024 Market

Pure Cycle First Quarter 2024 Earnings: EPS: US$0.086 (vs US$0.007 in 1Q 2023)

Simply Wall St.

2 years ago

Pure Cycle First Quarter 2024 Earnings: EPS: US$0.086 (vs US$0.007 in 1Q 2023)

loanDepot Provides Update on Cyber Incident

Business Wire

2 years ago

loanDepot Provides Update on Cyber Incident

GlobeNewswire

2 years ago

QuantaSing Announces Appointment of New Independent Director

RiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Capital and Income Fund, Inc. Announce Preferred Dividends

Business Wire

2 years ago

RiverNorth Opportunities Fund, Inc., RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and RiverNorth Capital and Income Fund, Inc. Announce Preferred Dividends

Expensify Employees Purchase Common Shares

Business Wire

2 years ago

Expensify Employees Purchase Common Shares

ON24 Recognizes 2023’s Leaders in Digital Engagement

Business Wire

2 years ago

ON24 Recognizes 2023’s Leaders in Digital Engagement

Verastem Oncology Granted Fast Track Designation for Combination of Avutometinib and Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)

Business Wire

2 years ago

Verastem Oncology Granted Fast Track Designation for Combination of Avutometinib and Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)

Pure Cycle Corporation (NASDAQ:PCYO) Q1 2024 Earnings Call Transcript

Insider Monkey

2 years ago

Pure Cycle Corporation (NASDAQ:PCYO) Q1 2024 Earnings Call Transcript

PRINCETON BANCORP, INC. AGREES TO ACQUIRE CORNERSTONE FINANCIAL CORPORATION

PR Newswire

2 years ago

PRINCETON BANCORP, INC. AGREES TO ACQUIRE CORNERSTONE FINANCIAL CORPORATION

Share on Social Networks: